Stock Analiz

Guardant Health, Inc. (GH) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Guardant Health’s revenue went from $25M in fiscal 2016 to $982M in fiscal 2025, growth of about 50.2% a year.

Net income in fiscal 2025 was -$416M, a net margin of -42.4%; the best year in this period was 2016 with -$46M.

Over the twelve months to September 30, 2026, revenue was $1.3B and net income -$485M.

Free cash flow was -$233M in fiscal 2025 and positive in 0 of the 10 years shown.

The diluted share count rose 860% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $25M162017: $50M172018: $91M182019: $214M192020: $287M202021: $374M212022: $450M222023: $564M232024: $739M242025: $982M25$982M
Net income
2016: -$46M162017: -$83M172018: -$85M182019: -$76M192020: -$254M202021: -$385M212022: -$655M222023: -$479M232024: -$436M242025: -$416M25-$416M
Free cash flow
2016: -$38M162017: -$79M172018: -$92M182019: -$66M192020: -$140M202021: -$284M212022: -$387M222023: -$345M232024: -$275M242025: -$233M25-$233M
EPS (diluted)
2016: $-3.53162017: $-7.07172018: $-2.80182019: $-0.84192020: $-2.60202021: $-4.00212022: $-6.41222023: $-4.28232024: $-3.56242025: $-3.3225$-3.32

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$1.3B$982M$739M$564M$450M$374M$287M$214M$91M$50M$25M
Gross profit$834M$633M$449M$337M———————
Operating income-$504M-$437M-$444M-$565M-$544M-$411M-$255M-$82M-$93M-$77M-$44M
Net income-$485M-$416M-$436M-$479M-$655M-$385M-$254M-$76M-$85M-$83M-$46M
EPS (diluted)$-3.68$-3.32$-3.56$-4.28$-6.41$-4.00$-2.60$-0.84$-2.80$-7.07$-3.53
R&D$387M$364M$348M$367M$374M$263M$150M$86M$51M$26M$11M
Revenue growth—+32.9%+31.0%+25.4%+20.3%+30.3%+33.8%+136.5%+81.8%+97.4%—

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow-$173M-$185M-$240M-$325M-$309M-$209M-$104M-$47M-$72M-$72M-$37M
Capital spending-$59M-$48M-$35M-$20M-$77M-$75M-$36M-$19M-$20M-$7M-$2M
Free cash flow-$232M-$233M-$275M-$345M-$387M-$284M-$140M-$66M-$92M-$79M-$38M
Dividends paid$0$0$0$0$0$0$0$0———
Buybacks$0$45M$0$0——$0$0$172000$7M$100000
Stock-based pay$211M$166M$140M$91M$95M$151M$144M$17M$7M$4M$2M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$1.2B$840M$1.2B$1.0B$933M$1.8B$523M$419M$221M$34M
Debt—$1.7B$1.3B$1.4B$1.4B$1.4B$854M$40M$22M——
Equity—-$99M-$140M$159M$60M$645M$1.3B$798M$483M$309M$80M
Total assets—$2.0B$1.5B$1.8B$1.6B$2.2B$2.3B$963M$587M$343M—
Shares (diluted)134M125M123M112M102M101M98M91M30M13M13M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin65.2%64.5%60.8%59.7%———————
Operating margin-39.4%-44.5%-60.0%-100.1%-121.1%-110.0%-88.9%-38.4%-102.5%-153.7%-173.7%
Net margin-37.9%-42.4%-59.1%-85.0%-145.6%-103.0%-88.5%-35.3%-93.8%-167.0%-182.7%
FCF margin-18.2%-23.7%-37.2%-61.3%-86.1%-76.0%-48.9%-30.7%-101.9%-158.3%-152.4%
ROIC—-27.1%-29.3%-29.5%-30.1%-16.1%-9.3%-9.6%-14.5%-19.6%-43.5%
ROE—419.2%312.5%-302.1%-1087.7%-59.7%-19.5%-9.5%-17.6%-27.0%-57.9%

Frequently asked questions

What is Guardant Health’s annual revenue?

$982M in fiscal 2025 and $1.3B over the twelve months to September 30, 2026.

How much profit does Guardant Health make?

Net income was -$416M in fiscal 2025 (net margin -42.4%).

Is Guardant Health’s revenue growing?

Yes: revenue rose 32.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.